Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Hasenkamp

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
Frontiers in Molecular Biosciences|June 6, 2020
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-CellsThomas Mika, Abdelouahid Maghnouj, Susanne Klein-Scory, et al.
Frontiers in Immunology|October 25, 2021
Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA AssociationsRebecca Isabel Wurm-Kuczera, Judith Buentzel, Julia Felicitas Leni Koenig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
The Lancet. Oncology|May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trialBertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
Bone Marrow Transplantation|March 17, 2024
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
BMC Infectious Diseases|April 26, 2022
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune studyAlexandra Dopfer-Jablonka, Sandra Steffens, Frank Müller, et al.
Annals of Hematology|September 30, 2020
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Boris Böll, Enrico Schalk, Dieter Buchheidt, et al.
Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Cancers|August 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective AnalysisEvgenii Shumilov, Lena Aperdannier, Nicole Schmidt, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
Frontiers in Molecular Biosciences|June 6, 2020
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-CellsThomas Mika, Abdelouahid Maghnouj, Susanne Klein-Scory, et al.
Frontiers in Immunology|October 25, 2021
Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA AssociationsRebecca Isabel Wurm-Kuczera, Judith Buentzel, Julia Felicitas Leni Koenig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
The Lancet. Oncology|May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trialBertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
Bone Marrow Transplantation|March 17, 2024
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
BMC Infectious Diseases|April 26, 2022
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune studyAlexandra Dopfer-Jablonka, Sandra Steffens, Frank Müller, et al.
Annals of Hematology|September 30, 2020
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Boris Böll, Enrico Schalk, Dieter Buchheidt, et al.
Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Cancers|August 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective AnalysisEvgenii Shumilov, Lena Aperdannier, Nicole Schmidt, et al.
Pageof 4